Top Back to top

Non-interventional prospective study on the on the effect of 2nd generation TKI prior to HSCT in CML

Chronic Malignancies Working Party (CMWP)
Study number:
Type of transplant:
Short title:
Study status:
Deadline for data collection:
Study design:
Primary objective:
Key inclusion criteria:
>18years old; allogeneic HSCT; CML; Dasatinib or Nilotinib
Principal investigator:
Michael Schleuning
Principal investigator email:
EBMT Study coordinator:
Jennifer Hoek